The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s studies explore adding nimotuzumab to chemotherapy to treat KRAS wild-type pancreatic cancer and adding ibrutinib to standard care for older adults with mantle cell lymphoma. Read More >>
pancreatic cancer
June 3, 2022 · Greg Guthrie, ASCO staff
February 14, 2022 · Greg Guthrie, ASCO staff
Read research from the February 2022 session of the ASCO Plenary Series, which highlights a study on daily aspirin to prevent breast cancer recurrence and another on using targeted therapy to treat advanced pancreatic cancer with a specific mutation. Read More >>
September 16, 2021 · Mark A. Lewis, MD
Dr. Mark A. Lewis describes what the Whipple procedure is, including who might receive it, what his personal experience with the operation was like, how to prepare, and what to expect during recovery from the operation. Read More >>
June 22, 2021 · Arjun Gupta, MD
Dr. Arjun Gupta explains what pancreatic enzyme replacement therapy is, why it may be offered to people with pancreatic cancer, and what to expect if you’re receiving this supportive care therapy. Read More >>
February 4, 2020 · Brielle Gregory, ASCO staff
The 2020 Advance of the Year in ASCO’s Clinical Cancer Advances report is the refinement of surgical treatment of cancer. Read More >>
